📚 Lecture Overview
This lecture covers toxoplasmosis, a major zoonotic parasitic disease caused by the obligate intracellular protozoan Toxoplasma gondii. It details the parasite's morphology, life cycle, transmission routes, pathogenesis, and immune evasion mechanisms. Understanding these principles is critical for diagnosing and managing acute, chronic, congenital, and opportunistic infections, particularly in immunocompromised individuals (such as AIDS patients) and pregnant women.
🎯 Key Concepts & Definitions
- Toxoplasma gondii: An obligate intracellular protozoan capable of invading any nucleated mammalian or avian cell, with a predilection for reticuloendothelial cells.
- Definitive Host (DH): Cats and other felines, in which the sexual cycle occurs and oocysts are shed.
- Reservoir Host: All mammals and birds.
- Tachyzoite: Fast-dividing, crescent-shaped stage inside pseudocysts; responsible for acute infection, tissue destruction, and transplacental transmission.
- Bradyzoite: Slowly dividing stage enclosed inside true tissue cysts; responsible for chronic (latent) infection, persisting mainly in neural and ocular tissue.
- Oocyst: The environmental resistant stage shed unsporulated in cat feces, which matures in soil into a form containing two sporocysts (each with 4 sporozoites).
- Parasitophorous Vacuole: A specialized intracellular structure formed by the parasite inside host cells that sequesters it from phagolysosomal fusion and host immune destruction.
📖 Main Content
1. Morphology & Stages of T. gondii
| Stage | Structure & Characteristics | Clinical Significance |
|---|---|---|
| Tachyzoite | Crescent-shaped ($2\,\mum × 5\,\mum$), rounded posterior, pointed apical end; contained in pseudocysts. | Rapidly replicates; mediates acute pathology, dissemination, and congenital transmission. |
| Bradyzoite | Smaller than tachyzoites, slow-dividing; enclosed within thick-walled true tissue cysts. | Latent/chronic infection; persists for host lifetime in brain and eyes; can reactivate if immunity drops. |
| Mature Oocyst | Rounded to oval; contains 2 sporocysts, each with 4 sporozoites (total 8 sporozoites). | Formed after 3–5 days in soil; highly resistant environmental infective stage. |
2. Transmission Routes
Humans acquire infection via:
1. Ingestion of undercooked meat containing tissue cysts (bradyzoites).
2. Ingestion of contaminated food or water containing mature oocysts from cat feces.
3. Transplacental (vertical) transmission of tachyzoites from mother to fetus.
4. Blood transfusion or organ transplantation (transmission of tachyzoites or cysts).
5. Consumption of unpasteurized milk or contaminated blood products (tachyzoites).
3. Pathogenesis & Clinical Manifestations
flowchart TD
A[Tachyzoite Entry] --> B[Parasitophorous Vacuole Formation]
B --> C[Evasion of Phagolysosomes]
C --> D{Host Immune Status}
D -->|Immunocompetent| E[Immune Control]
E --> F[Conversion to Bradyzoites in Cysts]
F --> G[Latent Chronic Infection]
D -->|Immunocompromised| H[Cyst Rupture and Tachyzoite Proliferation]
H --> I[Necrosis, Encephalitis, Myocarditis, Death]
- Immune Evasion: Fast invasion of nucleated cells and isolation within a parasitophorous vacuole prevents phagolysosome fusion.
- Immunocompetent Individuals:
- Tachyzoites produce local necrotic foci surrounded by a cellular inflammatory reaction.
- Immune response halts acute proliferation and forces conversion into bradyzoites (latent tissue cysts).
- Immunocompromised Patients (e.g., AIDS, transplant recipients):
- Rupture of latent tissue cysts releases bradyzoites that transform into destructive tachyzoites.
- Leading opportunistic infection in AIDS causing severe encephalitis (fatal in >30% of untreated cases), pneumonitis, myocarditis, and ocular toxoplasmosis.
- Congenital Toxoplasmosis:
- Transmitted transplacentally during acute maternal infection.
- Severity is inversely related to gestational age: earlier infection leads to higher severity (severe brain damage, calcification, organomegaly, death).
4. Diagnostic Modalities
- Direct Methods: Demonstration of parasites in biopsy specimens or lymph node aspirates.
- Molecular Methods: PCR detecting T. gondii nucleic acids or specific proteins (standard for amniotic fluid and tissue samples).
- Serological (Indirect) Tests:
- IgM: Appears within 1–2 weeks (indicates recent/acute infection).
- IgG: Appears within 4 weeks (indicates past/established infection).
- Assays used: ELISA, Sabin-Feldman dye test, IFA, MAT.
- IgG Avidity Test: High avidity rules out recent infection (differentiates chronic from acute/reactivated infection).
- Radiological Tests:
- Brain CT/MRI: Demonstrates characteristic ring-enhancing lesions and intracranial calcifications.
- Antenatal Ultrasound: Detects intrauterine fetal organomegaly and ventriculomegaly.
5. Treatment and Prophylaxis
Crucial Rule: All current therapeutic medications target only tachyzoites, not the encysted bradyzoites!
- Immunocompetent (Symptomatic Acute Disease) (6-week course):
- Pyrimethamine + Sulfadiazine + Folic acid OR
- Pyrimethamine + Clindamycin + Folic acid
- Pregnant Women:
- Spiramycin is administered to prevent or decrease the risk of vertical transmission to the fetus.
- HIV/AIDS Patients with Symptomatic Toxoplasmosis:
- Pyrimethamine + Sulfadiazine + Folic acid for life (maintenance therapy).
- Prophylaxis in AIDS Patients (to prevent reactivation):
- Co-trimoxazole (TMP-SMX) + antiretroviral therapy (ART).
- Given until $CD4^+ count > 200 cells/mm^3$ on ART.
📊 Visual Learning
mindmap
root("Toxoplasma gondii")
"Stages"
"Tachyzoites fast acute"
"Bradyzoites slow chronic"
"Oocysts cat feces"
"Hosts"
"Definitive Cats"
"Intermediate All mammals"
"Diagnostics"
"Serology IgM and IgG"
"PCR Molecular"
"CT Ring lesions"
"Treatment"
"Pyrimethamine Sulfadiazine"
"Spiramycin in pregnancy"
"Cotrimoxazole prophylaxis"
sequenceDiagram
participant C as Cat Definitive Host
participant E as Environment Soil
participant I as Intermediate Host or Human
participant F as Fetus or Organs
C ->> E: Sheds unsporulated oocysts
E ->> E: Sporulation in 3 to 5 days
E ->> I: Ingestion of mature oocysts
I ->> I: Tachyzoites cause acute disease
I ->> I: Bradyzoite cysts in brain and eyes
I ->> F: Tachyzoites cross placenta
💡 Important Points to Remember
- Cats are the ONLY definitive hosts; all other infected animals and humans act as intermediate/reservoir hosts.
- Tachyzoites = rapidly dividing, acute stage, pseudocysts, crosses placenta.
- Bradyzoites = slowly dividing, chronic stage, true cysts, persist for host lifetime in CNS and eyes.
- Mature oocyst composition: Contains 2 sporocysts, each containing 4 sporozoites (total = 8 sporozoites per mature oocyst).
- Sporulation takes 3 to 5 days outside the cat host in soil.
- T. gondii forms a parasitophorous vacuole to avoid phagolysosome fusion.
- Spiramycin is the drug of choice in pregnancy to protect the fetus from vertical transmission.
- Available anti-toxoplasma drugs act only on tachyzoites; they cannot eliminate chronic tissue cysts (bradyzoites).
- Prophylaxis with Co-trimoxazole (TMP-SMX) is discontinued in HIV patients once CD4 counts recover above 200 cells/mm³.
⚠️ Common Exam Questions & Traps
Exam Traps & Tricky Concepts
- Definitive vs. Reservoir Host:
- Trap: Calling humans or sheep definitive hosts.
- Fact: Felines (cats) are the only definitive hosts. All other animals are intermediate/reservoir hosts. - Oocyst Shedding Status:
- Trap: Freshly passed cat feces contain infective oocysts immediately.
- Fact: Oocysts are shed unsporulated (non-infectious) and require 3–5 days in soil to sporulate and become infectious. - Stage Responsible for Congenital Infection:
- Trap: Bradyzoites or oocysts cross the placenta.
- Fact: Only tachyzoites can invade and cross the placenta to the fetus. - Drug Target Limitations:
- Trap: Claiming pyrimethamine/sulfadiazine eradicates latent brain cysts.
- Fact: Current therapies only eradicate tachyzoites, having no effect on quiescent bradyzoite tissue cysts.
Sample Exam Vignettes
- Question: An AIDS patient with a CD4 count of $80 cells/mm^3$ presents with seizures and multiple ring-enhancing lesions on brain CT. What is the most likely mechanism?
- Answer: Reactivation of latent tissue cysts releasing bradyzoites that transform into destructive tachyzoites, causing toxoplasmic encephalitis.
- Question: A pregnant woman tests positive for acute toxoplasmosis. Which drug is given to reduce the risk of transmission to the fetus?
- Answer: Spiramycin.
📝 Quick Review Checklist
I can state the definitive host (cats) and intermediate hosts (all mammals/birds).
I can differentiate tachyzoites (acute, pseudocysts) from bradyzoites (chronic, true cysts).
I know the structure of a mature oocyst (2 sporocysts with 4 sporozoites each).
I can explain the function of the parasitophorous vacuole in immune evasion.
I know the serological timeline (IgM at 1–2 weeks, IgG at 4 weeks) and IgG avidity testing.
I can identify the radiological hallmark on CT (ring-enhancing lesions and brain calcifications).
I know the drug of choice for pregnant patients (Spiramycin) vs. acute symptomatic patients (Pyrimethamine + Sulfadiazine + Folic acid).
I know when to stop Co-trimoxazole prophylaxis in HIV patients (CD4 > 200 cells/mm³).